Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 1884

1.
3.

Prevention of major venous thromboembolism following total hip or knee replacement: a randomized comparison of low-molecular-weight heparin with unfractionated heparin (ECHOS Trial).

Haas S, Breyer HG, Bacher HP, Fareed J, Misselwitz F, Victor N, Weber J; ECHOS Trial Group..

Int Angiol. 2006 Dec;25(4):335-42.

PMID:
17164738
4.
5.

Comparison of the oral direct thrombin inhibitor ximelagatran with enoxaparin as prophylaxis against venous thromboembolism after total knee replacement: a phase 2 dose-finding study.

Heit JA, Colwell CW, Francis CW, Ginsberg JS, Berkowitz SD, Whipple J, Peters G; AstraZeneca Arthroplasty Study Group..

Arch Intern Med. 2001 Oct 8;161(18):2215-21.

PMID:
11575978
6.

Preoperative or postoperative start of prophylaxis for venous thromboembolism with low-molecular-weight heparin in elective hip surgery?

Strebel N, Prins M, Agnelli G, Büller HR.

Arch Intern Med. 2002 Jul 8;162(13):1451-6. Review.

PMID:
12090880
7.

Prolonged enoxaparin therapy to prevent venous thromboembolism after primary hip or knee replacement. A cost-utility analysis.

Haentjens P, De Groote K, Annemans L.

Arch Orthop Trauma Surg. 2004 Oct;124(8):507-17. Epub 2004 Sep 10.

PMID:
15365714
8.

Extended venous thromboembolism prophylaxis after total hip replacement: a comparison of low-molecular-weight heparin with oral anticoagulant.

Samama CM, Vray M, Barré J, Fiessinger JN, Rosencher N, Lecompte T, Potron G, Basile J, Hull R, Desmichels D; SACRE Study Investigators..

Arch Intern Med. 2002 Oct 28;162(19):2191-6.

PMID:
12390061
10.
11.
12.

A prospective observational study on the effectiveness and safety of bemiparin, first dose administered 6 h after knee or hip replacement surgery.

Abad JI, Gómez-Outes A, Martínez-González J, Rocha E; Bemiparin 6 Hours After Surgery Study Group..

Arch Orthop Trauma Surg. 2007 Oct;127(8):665-70. Epub 2006 Nov 7.

PMID:
17089172
13.
14.

Clinical experience with ximelagatran in orthopaedic surgery.

Eriksson B.

Drugs. 2004;64 Suppl 1:27-35. Review.

PMID:
15586625
15.

A phase II study of the oral factor Xa inhibitor LY517717 for the prevention of venous thromboembolism after hip or knee replacement.

Agnelli G, Haas S, Ginsberg JS, Krueger KA, Dmitrienko A, Brandt JT.

J Thromb Haemost. 2007 Apr;5(4):746-53.

16.

High incidence of in-hospital pulmonary embolism following joint arthroplasty with dalteparin prophylaxis.

Kerr J, Linkins LA.

Thromb Haemost. 2010 Jan;103(1):123-8. doi: 10.1160/TH09-07-0438. Epub 2009 Oct 26.

PMID:
20062935
17.

The Mark Coventry Award: Prevention of readmission for venous thromboembolism after total knee arthroplasty.

Pellegrini VD Jr, Donaldson CT, Farber DC, Lehman EB, Evarts CM.

Clin Orthop Relat Res. 2006 Nov;452:21-7.

PMID:
16906107
18.
19.
20.

Extended out-of-hospital low-molecular-weight heparin prophylaxis against deep venous thrombosis in patients after elective hip arthroplasty: a systematic review.

Hull RD, Pineo GF, Stein PD, Mah AF, MacIsaac SM, Dahl OE, Butcher M, Brant RF, Ghali WA, Bergqvist D, Raskob GE.

Ann Intern Med. 2001 Nov 20;135(10):858-69. Review.

PMID:
11712876

Supplemental Content

Support Center